Cargando…

Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review

BACKGROUND: People living with diabetes often experience multiple morbidity and polypharmacy, increasing their risk of potentially inappropriate prescribing. Inappropriate prescribing is associated with poorer health outcomes. AIM: The aim of this scoping review was to explore and map studies conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayalew, Mohammed Biset, Spark, M. Joy, Quirk, Frances, Dieberg, Gudrun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393152/
https://www.ncbi.nlm.nih.gov/pubmed/35776376
http://dx.doi.org/10.1007/s11096-022-01414-7
_version_ 1784771208005287936
author Ayalew, Mohammed Biset
Spark, M. Joy
Quirk, Frances
Dieberg, Gudrun
author_facet Ayalew, Mohammed Biset
Spark, M. Joy
Quirk, Frances
Dieberg, Gudrun
author_sort Ayalew, Mohammed Biset
collection PubMed
description BACKGROUND: People living with diabetes often experience multiple morbidity and polypharmacy, increasing their risk of potentially inappropriate prescribing. Inappropriate prescribing is associated with poorer health outcomes. AIM: The aim of this scoping review was to explore and map studies conducted on potentially inappropriate prescribing among adults living with diabetes and to identify gaps regarding identification and assessment of potentially inappropriate prescribing in this group. METHOD: Studies that reported any type of potentially inappropriate prescribing were included. Studies conducted on people aged < 18 years or with a diagnosis of gestational diabetes or prediabetes were excluded. No restrictions to language, study design, publication status, geographic area, or clinical setting were applied in selecting the studies. Articles were systematically searched from 11 databases. RESULTS: Of the 190 included studies, the majority (63.7%) were conducted in high-income countries. None of the studies used an explicit tool specifically designed to identify potentially inappropriate prescribing among people with diabetes. The most frequently studied potentially inappropriate prescribing in high-income countries was contraindication while in low- and middle-income countries prescribing omission was the most common. Software and websites were mostly used for identifying drug-drug interactions. The specific events and conditions that were considered as inappropriate were inconsistent across studies. CONCLUSION: Contraindications, prescribing omissions and dosing problems were the most commonly studied types of potentially inappropriate prescribing. Prescribers should carefully consider the individual prescribing recommendations of medications. Future studies focusing on the development of explicit tools to identify potentially inappropriate prescribing for adults living with diabetes are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01414-7.
format Online
Article
Text
id pubmed-9393152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93931522022-08-23 Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review Ayalew, Mohammed Biset Spark, M. Joy Quirk, Frances Dieberg, Gudrun Int J Clin Pharm Review Article BACKGROUND: People living with diabetes often experience multiple morbidity and polypharmacy, increasing their risk of potentially inappropriate prescribing. Inappropriate prescribing is associated with poorer health outcomes. AIM: The aim of this scoping review was to explore and map studies conducted on potentially inappropriate prescribing among adults living with diabetes and to identify gaps regarding identification and assessment of potentially inappropriate prescribing in this group. METHOD: Studies that reported any type of potentially inappropriate prescribing were included. Studies conducted on people aged < 18 years or with a diagnosis of gestational diabetes or prediabetes were excluded. No restrictions to language, study design, publication status, geographic area, or clinical setting were applied in selecting the studies. Articles were systematically searched from 11 databases. RESULTS: Of the 190 included studies, the majority (63.7%) were conducted in high-income countries. None of the studies used an explicit tool specifically designed to identify potentially inappropriate prescribing among people with diabetes. The most frequently studied potentially inappropriate prescribing in high-income countries was contraindication while in low- and middle-income countries prescribing omission was the most common. Software and websites were mostly used for identifying drug-drug interactions. The specific events and conditions that were considered as inappropriate were inconsistent across studies. CONCLUSION: Contraindications, prescribing omissions and dosing problems were the most commonly studied types of potentially inappropriate prescribing. Prescribers should carefully consider the individual prescribing recommendations of medications. Future studies focusing on the development of explicit tools to identify potentially inappropriate prescribing for adults living with diabetes are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01414-7. Springer International Publishing 2022-07-01 2022 /pmc/articles/PMC9393152/ /pubmed/35776376 http://dx.doi.org/10.1007/s11096-022-01414-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Ayalew, Mohammed Biset
Spark, M. Joy
Quirk, Frances
Dieberg, Gudrun
Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
title Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
title_full Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
title_fullStr Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
title_full_unstemmed Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
title_short Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
title_sort potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393152/
https://www.ncbi.nlm.nih.gov/pubmed/35776376
http://dx.doi.org/10.1007/s11096-022-01414-7
work_keys_str_mv AT ayalewmohammedbiset potentiallyinappropriateprescribingforadultslivingwithdiabetesmellitusascopingreview
AT sparkmjoy potentiallyinappropriateprescribingforadultslivingwithdiabetesmellitusascopingreview
AT quirkfrances potentiallyinappropriateprescribingforadultslivingwithdiabetesmellitusascopingreview
AT dieberggudrun potentiallyinappropriateprescribingforadultslivingwithdiabetesmellitusascopingreview